HilleVax, Inc. / Fundamentals

    Income statement

    Net revenue
    €0.00
    Cost of goods sold
    €0.00
    Gross profit
    €0.00
    SG&A expenses
    €20.23M
    R&D expenses
    €24.95M
    EBITDA
    -€59.22M
    D&A
    €2.30M
    EBIT
    -€66.56M
    Interest expenses
    €1.60M
    EBT
    -€61.36M
    Tax expenses
    €0.00
    Net income
    -€61.36M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    €5.28M
    Changes in working capital
    -€9.92M
    Operating cash flow
    -€51.37M
    Capex
    €1.57M
    Other investing cash flow
    -€13.23M
    Net investing cash flow
    €32.15M
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €0.00
    Debt repayment
    -€23.73M
    Other financing cash flow
    €0.00
    Net financing cash flow
    -€23.73M
    Foreign exchange effects
    €0.00
    Net change in cash
    -€42.95M
    Cash at end of period
    €52.05M
    Free cash flow
    -€49.79M

    Balance sheet

    Cash and cash equivalents
    €50.64M
    Cash and short-term investments
    €137.69M
    Total receivables
    €0.00
    Inventory
    €0.00
    Other current assets
    €2.33M
    Total current assets
    €140.02M
    Property, plant & equipment
    €9.51M
    Goodwill
    €0.00
    Intangible assets
    €0.00
    Long-term investments
    €0.00
    Other non-current assets
    €1.43M
    Total non-current assets
    €10.94M
    Total assets
    €150.96M
    Accounts payable
    €97.52K
    Short-term debt
    €3.13M
    Other current liabilities
    €2.07M
    Total current liabilities
    €5.31M
    Long-term debt
    €17.18M
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €894.11K
    Total non-current liabilities
    €18.08M
    Total liabilities
    €23.38M
    Common stock
    €4.32K
    Retained earnings
    -€472.21M
    Other equity
    -€1.07M
    Total equity
    €127.57M
    Total liabilities and shareholders' equity
    €150.96M

    Company information

    Market capitalization
    €84.25M
    Employees
    14
    Enterprise Value
    €74.83M

    Company ratios

    Gross margin
    0.0%
    EBITDA margin
    0.0%
    EBIT margin
    0.0%
    EBT margin
    0.0%
    Net margin
    0.0%
    ROE
    -48.1% Much better than peer group: -71.8%
    ROA
    -40.6% Much better than peer group: -193.0%
    Asset turnover
    0.0%
    FCF margin
    0.0%
    FCF yield
    -62.8%
    Efficiency ratio
    0.0%
    Net sales per employee
    €0.00
    Net income per employee
    -€4.38M

    Notifications